Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?
Katja Thümmler(Institute of Infection and Immunity), Christopher Linington(University of Glasgow), Diana Arseni(MRC Laboratory of Molecular Biology), Christine Stadelmann(Universitätsmedizin Göttingen), Lorna Hayden(University of Glasgow), Friedrich Schwarz(Universitätsmedizin Göttingen), Sebastian Kügler(Hertie Foundation), Claudia Wrzos(Universitätsmedizin Göttingen), Andreas Junker(University of Göttingen), Fred Wolf(Max Planck Institute for Dynamics and Self-Organization), Andreas Neef(Max Planck Institute for Dynamics and Self-Organization), Jonas Franz(Boston University), John Cole(University of Glasgow), Daniel McElroy(University of Glasgow), Julia M. Edgar(University of Glasgow)
Cited by 7
Related Papers
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
|Brain Pathology|2008|479
Cryo-EM structures of amyloid-β 42 filaments from human brains
|UCL Discovery (University College London)|2022|422
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium
|Acta Neuropathologica|2009|329
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|315
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304